<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30181360</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>04</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>04</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1549-5477</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>32</Volume>                    <Issue>17-18</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>09</Month>                        <Day>01</Day>                    </PubDate>                </JournalIssue>                <Title>Genes &amp; development</Title>                <ISOAbbreviation>Genes Dev.</ISOAbbreviation>            </Journal>            <ArticleTitle>Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>1141-1154</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1101/gad.316646.118</ELocationID>            <Abstract>                <AbstractText>Estrogen receptor α (ER) is the major driver of ∼75% of breast cancers, and multiple ER targeting drugs are routinely used clinically to treat patients with ER<sup>+</sup> breast cancer. However, many patients relapse on these targeted therapies and ultimately develop metastatic and incurable disease, and understanding the mechanisms leading to drug resistance is consequently of utmost importance. It is now clear that, in addition to estrogens, ER function is modulated by other steroid receptors and multiple signaling pathways (e.g., growth factor and cytokine signaling), and many of these pathways affect drug resistance and patient outcome. Here, we review the mechanisms through which these pathways impact ER function and drug resistance as well as discuss the clinical implications.</AbstractText>                <CopyrightInformation>© 2018 Siersbæk et al.; Published by Cold Spring Harbor Laboratory Press.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Siersbæk</LastName>                    <ForeName>Rasmus</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kumar</LastName>                    <ForeName>Sanjeev</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Addenbrookes Hospital, Cambridge CB2 0QQ, United Kingdom.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Carroll</LastName>                    <ForeName>Jason S</ForeName>                    <Initials>JS</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <Agency>Cancer Research UK</Agency>                    <Country>United Kingdom</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Genes Dev</MedlineTA>            <NlmUniqueID>8711660</NlmUniqueID>            <ISSNLinking>0890-9369</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D047628">Estrogen Receptor alpha</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D036341">Intercellular Signaling Peptides and Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011987">Receptors, Steroid</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C506487">estrogen receptor alpha, human</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2018 May 8;8(1):7139</RefSource>                <PMID Version="1">29740030</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Med. 2008 May;14(5):518-27</RefSource>                <PMID Version="1">18438415</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Syst Rev. 2016 Jul 26;5(1):121</RefSource>                <PMID Version="1">27456847</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2015 Mar;46(3):933-43</RefSource>                <PMID Version="1">25573346</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA Oncol. 2016 Oct 1;2(10):1310-1315</RefSource>                <PMID Version="1">27532364</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 1998 Apr;18(4):1978-84</RefSource>                <PMID Version="1">9528769</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1980 Dec 1;46(11):2369-72</RefSource>                <PMID Version="1">7438013</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Ther. 2013 Oct;30(10):870-84</RefSource>                <PMID Version="1">24158787</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Dev. 2010 Oct 1;24(19):2219-27</RefSource>                <PMID Version="1">20889718</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2009 Aug 1;69(15):6131-40</RefSource>                <PMID Version="1">19638585</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Invest. 2010 Jul;120(7):2406-13</RefSource>                <PMID Version="1">20530877</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocrinology. 2009 Jul;150(7):2988-90</RefSource>                <PMID Version="1">19549883</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2009 Mar 6;284(10):6361-9</RefSource>                <PMID Version="1">19112174</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2001 Jul 15;19(14):3357-66</RefSource>                <PMID Version="1">11454883</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Endocrinol. 2015 Sep;29(9):1230-42</RefSource>                <PMID Version="1">26266959</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA Oncol. 2018 Jul 1;4(7):977-984</RefSource>                <PMID Version="1">29566104</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2010 Mar 15;16(6):1904-14</RefSource>                <PMID Version="1">20215537</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Res. 2013 Jan;23(1):12-22</RefSource>                <PMID Version="1">23172872</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 2012 Jan;32(2):569-75</RefSource>                <PMID Version="1">22083956</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2011 Oct 15;71(20):6360-70</RefSource>                <PMID Version="1">21868756</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2014 Feb 17;4:4057</RefSource>                <PMID Version="1">24531845</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 1995 Dec 1;270(5241):1491-4</RefSource>                <PMID Version="1">7491495</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 1978 Apr 10;253(7):2223-8</RefSource>                <PMID Version="1">632265</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2015 Jul 16;523(7560):313-7</RefSource>                <PMID Version="1">26153859</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocrinology. 2009 Jul;150(7):3318-26</RefSource>                <PMID Version="1">19342456</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2006 Sep 20;98(18):1285-91</RefSource>                <PMID Version="1">16985247</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2016 Jun 1;22(11):2650-8</RefSource>                <PMID Version="1">26783290</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>EMBO J. 2011 May 13;30(13):2569-81</RefSource>                <PMID Version="1">21572391</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2014 Jan 22;16(1):R7</RefSource>                <PMID Version="1">24451109</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 1981;1(2):125-30</RefSource>                <PMID Version="1">6216931</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2011 Aug 27;378(9793):771-84</RefSource>                <PMID Version="1">21802721</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Transl Med. 2015 Sep 16;7(305):305ps19</RefSource>                <PMID Version="1">26378243</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2015 Jul;16(7):816-29</RefSource>                <PMID Version="1">26092818</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2002 Jul;2(7):489-501</RefSource>                <PMID Version="1">12094235</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2016 May;27(5):812-8</RefSource>                <PMID Version="1">27052658</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2014 Aug;40(7):862-71</RefSource>                <PMID Version="1">24774538</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2018 May 1;24(9):2050-2059</RefSource>                <PMID Version="1">29066505</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2012 Oct 1;323(1):77-87</RefSource>                <PMID Version="1">22484466</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):109-15</RefSource>                <PMID Version="1">21390570</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Endocrinol. 2011 Mar;25(3):516-28</RefSource>                <PMID Version="1">21292829</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS Med. 2010 May 25;7(5):e1000279</RefSource>                <PMID Version="1">20520800</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Urol. 2013 Aug;10(8):483-7</RefSource>                <PMID Version="1">23752995</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2009 May 1;69(9):3955-62</RefSource>                <PMID Version="1">19366795</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2018 Mar 20;36(9):884-890</RefSource>                <PMID Version="1">29373071</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2014 Apr;25(4):831-6</RefSource>                <PMID Version="1">24615412</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1991 Feb 15;67(4):886-91</RefSource>                <PMID Version="1">1991261</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2016 Mar 14;29(3):407-422</RefSource>                <PMID Version="1">26947176</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 2015 Apr 2;58(1):21-34</RefSource>                <PMID Version="1">25752574</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2014 May;15(6):580-91</RefSource>                <PMID Version="1">24742739</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>EMBO J. 1996 May 1;15(9):2174-83</RefSource>                <PMID Version="1">8641283</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2017 Apr 1;23(7):1710-1721</RefSource>                <PMID Version="1">27702820</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2008 Mar 28;8:84</RefSource>                <PMID Version="1">18373855</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 2017 May 4;66(3):321-331.e6</RefSource>                <PMID Version="1">28475868</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2017 Apr 20;36(16):2286-2296</RefSource>                <PMID Version="1">27748765</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2006 Feb 15;66(4):2202-9</RefSource>                <PMID Version="1">16489022</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Biol Ther. 2012 Jan 1;13(1):14-24</RefSource>                <PMID Version="1">22336584</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Oncol. 1985 Mar;12(1 Suppl 1):43-7</RefSource>                <PMID Version="1">3975652</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2011 Jul 20;29(21):2845-51</RefSource>                <PMID Version="1">21670457</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:264-72</RefSource>                <PMID Version="1">25597633</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Trends Biochem Sci. 2014 Apr;39(4):170-82</RefSource>                <PMID Version="1">24674738</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 1998 May 22;273(21):13317-23</RefSource>                <PMID Version="1">9582378</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2012 Jun;133(3):1049-56</RefSource>                <PMID Version="1">22418699</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2018 Feb 12;33(2):173-186.e5</RefSource>                <PMID Version="1">29438694</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2015 Aug 1;386(9992):433-43</RefSource>                <PMID Version="1">26040499</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Discov. 2017 Mar;7(3):277-287</RefSource>                <PMID Version="1">27986707</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2013 Jul 25;32(30):3543-51</RefSource>                <PMID Version="1">22907427</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2012 Jul 1;18(13):3562-70</RefSource>                <PMID Version="1">22573351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pathol. 2005 Oct;207(2):139-46</RefSource>                <PMID Version="1">16088978</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 2008 Dec;28(24):7487-503</RefSource>                <PMID Version="1">18838536</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2013 Oct 1;133(7):1589-602</RefSource>                <PMID Version="1">23553037</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2013 Jun 27;498(7455):516-20</RefSource>                <PMID Version="1">23728302</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2017 Sep 12;318(10):927-938</RefSource>                <PMID Version="1">28898378</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 1979 Apr;15(4):593-601</RefSource>                <PMID Version="1">86447</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2014 Dec 10;32(35):3959-66</RefSource>                <PMID Version="1">25348000</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>FEBS Lett. 2010 Jan 4;584(1):124-8</RefSource>                <PMID Version="1">19925796</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2015 Apr;150(2):335-46</RefSource>                <PMID Version="1">25762479</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Mol Med. 2014 Dec;18(12):2519-29</RefSource>                <PMID Version="1">25338520</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Rep. 2012 Mar;27(3):657-63</RefSource>                <PMID Version="1">22134540</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2017 Mar 24;355(6331):1324-1330</RefSource>                <PMID Version="1">28336670</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>EMBO J. 2002 Oct 15;21(20):5437-47</RefSource>                <PMID Version="1">12374744</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1999 Jan;17(1):64-73</RefSource>                <PMID Version="1">10458219</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Jan 04;481(7381):389-93</RefSource>                <PMID Version="1">22217937</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Res. 2013 Aug;23(8):1210-23</RefSource>                <PMID Version="1">23636943</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2014 Feb 4;110(3):565-72</RefSource>                <PMID Version="1">24300977</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2013 Aug 15;73(16):5130-9</RefSource>                <PMID Version="1">23803465</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2013 Apr 17;105(8):526-35</RefSource>                <PMID Version="1">23543779</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Res. 2016 Aug;14(8):707-19</RefSource>                <PMID Version="1">27141101</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2005 Nov 14;24(50):7455-64</RefSource>                <PMID Version="1">16288292</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2017 Jan 1;23(1):26-34</RefSource>                <PMID Version="1">27126994</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2015 Mar 30;107(6):djv048</RefSource>                <PMID Version="1">25825511</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2004;6(5):213-8</RefSource>                <PMID Version="1">15318928</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2018 Jan;62:18-28</RefSource>                <PMID Version="1">29154022</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2003 Apr 25;278(17):15192-200</RefSource>                <PMID Version="1">12576474</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2013 Aug 16;288(33):24020-34</RefSource>                <PMID Version="1">23814048</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2011 Mar 1;17(5):1147-59</RefSource>                <PMID Version="1">21220480</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2016 Jun;17(6):811-821</RefSource>                <PMID Version="1">27155741</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 1996 Mar;32A(3):404-12</RefSource>                <PMID Version="1">8814682</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mol Endocrinol. 2004 Jun;32(3):793-810</RefSource>                <PMID Version="1">15171713</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2010 Jan 15;126(2):545-62</RefSource>                <PMID Version="1">19609946</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 2000 Jul;6(1):127-37</RefSource>                <PMID Version="1">10949034</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Res. 2012 Aug;10(8):1120-32</RefSource>                <PMID Version="1">22669764</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2014 Dec;25(12):2357-62</RefSource>                <PMID Version="1">25231953</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1988 Jul;6(7):1098-106</RefSource>                <PMID Version="1">3292710</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2001 Mar 30;276(13):9817-24</RefSource>                <PMID Version="1">11139588</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2017 Jan;17(1):54-64</RefSource>                <PMID Version="1">27885264</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2017 Jul;18(7):904-916</RefSource>                <PMID Version="1">28576675</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Oct 4;490(7418):61-70</RefSource>                <PMID Version="1">23000897</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2013 Dec 1;73(23):6856-64</RefSource>                <PMID Version="1">24217577</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2008 Sep 15;68(18):7386-93</RefSource>                <PMID Version="1">18794126</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Ther. 2015 Nov;14(11):2508-18</RefSource>                <PMID Version="1">26358751</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Endocrinol. 2012 Nov;26(11):1941-52</RefSource>                <PMID Version="1">23023562</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2004 Jun;5(6):597-605</RefSource>                <PMID Version="1">15193262</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer. 2009 Nov 27;8:111</RefSource>                <PMID Version="1">19943940</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2011 Mar 01;13(2):R21</RefSource>                <PMID Version="1">21362200</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2005 Jul 15;11(14):5319-28</RefSource>                <PMID Version="1">16033851</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2016 Feb 10;34(5):419-26</RefSource>                <PMID Version="1">26503204</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Endocrinol Metab. 1983 Jun;56(6):1124-30</RefSource>                <PMID Version="1">6682424</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 1994 Feb 11;269(6):4458-66</RefSource>                <PMID Version="1">8308015</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Res. 2016 Nov;14(11):1054-1067</RefSource>                <PMID Version="1">27565181</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocr Rev. 2011 Oct;32(5):597-622</RefSource>                <PMID Version="1">21680538</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Genet. 2013 Dec;45(12):1446-51</RefSource>                <PMID Version="1">24185510</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Endocrinol. 2000 Sep 25;167(1-2):139-50</RefSource>                <PMID Version="1">11000528</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2015 Feb 12;518(7538):240-4</RefSource>                <PMID Version="1">25409150</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2002 Jul 25;21(32):4921-31</RefSource>                <PMID Version="1">12118371</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1997 Feb 15;79(4):730-9</RefSource>                <PMID Version="1">9024711</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2017 Jan;161(2):229-243</RefSource>                <PMID Version="1">27853906</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2014 Dec;25(12):2419-25</RefSource>                <PMID Version="1">25223486</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Steroids. 2014 Nov;90:94-100</RefSource>                <PMID Version="1">24945109</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Intern Med. 1983 Feb;98(2):139-44</RefSource>                <PMID Version="1">6824247</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Genet. 2011 Jan;43(1):27-33</RefSource>                <PMID Version="1">21151129</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 2017 Mar 16;65(6):1122-1135.e5</RefSource>                <PMID Version="1">28306507</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2017 Aug 14;32(2):169-184.e7</RefSource>                <PMID Version="1">28810143</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2008 Feb 8;132(3):344-62</RefSource>                <PMID Version="1">18267068</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2018 Feb 15;78(4):974-984</RefSource>                <PMID Version="1">29229606</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2015 Sep 8;6(26):21878-91</RefSource>                <PMID Version="1">26215677</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS Genet. 2011 Nov;7(11):e1002368</RefSource>                <PMID Version="1">22125492</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019008" MajorTopicYN="N">Drug Resistance, Neoplasm</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D047628" MajorTopicYN="N">Estrogen Receptor alpha</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D036341" MajorTopicYN="N">Intercellular Signaling Peptides and Proteins</DescriptorName>                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011987" MajorTopicYN="N">Receptors, Steroid</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="Y">breast cancer</Keyword>            <Keyword MajorTopicYN="Y">cross-talk</Keyword>            <Keyword MajorTopicYN="Y">cytokines</Keyword>            <Keyword MajorTopicYN="Y">estrogen receptor</Keyword>            <Keyword MajorTopicYN="Y">growth factors</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pmc-release">                <Year>2019</Year>                <Month>03</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>5</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30181360</ArticleId>            <ArticleId IdType="pii">32/17-18/1141</ArticleId>            <ArticleId IdType="doi">10.1101/gad.316646.118</ArticleId>            <ArticleId IdType="pmc">PMC6120708</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>